Latest / Medsolve Dynamics / Medsolve Dynamics is just beginning.
Transcript
- Yoel Bakas: After 20 years in this industry, today marks a very specific shift. I have spent my career structuring complex medtech deals from the manufacturer side, making sure advanced technology actually made it into clinical practice. I know the deal mechanics inside and out, and I also know exactly where the disconnects happen. often, there's a gap between the ROI on paper and the realities of the P &L. That gap is exactly where returns quietly evaporate. This next chapter is about closing that gap through Medsolve Dynamics, ensuring technology investments are mathematically successful, ⁓ just clinically ambitious. Radiation oncology operates at roughly a 75 % expense ratio. There is no margin for error. Recently, we helped a client realign technical specifications to actual workflows, unlocking $3 million in capital savings. No vendor relationships were damaged. In fact, we preserved them by making sure the hospital remained solvent and successful. To my network on both sides of the table, thank you for 20 years of trust and collaboration. If you know an administrator or physician group navigating clinical ambition and financial pressure heading into 2026, I'd welcome an introduction. This is the next chapter for Medsolve Dynamics and we are just getting started.